Our study demonstrated, according to our best knowledge, for the first time worldwide that among the demographic (age and gender), clinical (hormonal activity), and histopathological (PIT1, TPIT, transcriptionally active hrHPV infection) participant characteristics, the only factor that significantly affected the tumor invasiveness was transcriptionally active hrHPV infection. This evidence concerns the gene TBX19 and neoplasm.